Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis Ag ADR
(NY:
NVS
)
106.02
+0.47 (+0.45%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novartis Ag ADR
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
39
40
Next >
Sex Hormones Market to See Huge Growth by 2028 : Novartis, Sanofi, AstraZeneca, Merck
August 30, 2023
Sex Hormones- Comprehensive Study by Type (Progesterone, Testosterone, Drospirenone), Application (Topical, Inhalation, Injection, Others) Players and Region - Global Market Outlook to 2027
Via
SBWire
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
August 29, 2023
Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations.
Via
The Motley Fool
Transdermal Drug Patches Market to See Huge Growth : Novartis, Mylan, Accrux
August 29, 2023
Stay up-to-date with Transdermal Drug Patches Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Exposures
COVID-19
2 Excellent Stocks to Buy and Hold Forever
August 17, 2023
These companies have solid long-term potential.
Via
The Motley Fool
2 Top Biotech Stocks to Buy Right Now
August 14, 2023
These drugmakers are among the most dominant in the world.
Via
The Motley Fool
DTx Pharma Acquisition by Novartis Generates Robust Returns for Tech Coast Angels and NuFund Venture Group
August 03, 2023
IRVINE, Calif. - Aug. 3, 2023 - PRLog -- Tech Coast Angels (TCA) and NuFund Venture Group (formerly TCA-San Diego) today announced that portfolio company DTx Pharma was acquired by Swiss pharmaceutical...
Via
PRLog
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
August 29, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle
August 29, 2023
The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's Inflation Reduction Act, including:
Via
Benzinga
Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price Cuts
August 29, 2023
The Biden administration is planning to negotiate the prices of 10 drugs in 2026.
Via
Investor's Business Daily
3 AI Stocks With the Potential to Transform Your Financial Future
August 28, 2023
Are you looking to invest in AI stocks? Here are three picks with the potential to transform your financial future.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Emerging Market Stocks to Buy in August
August 28, 2023
These three emerging market stocks to buy in August will have very strong, positive catalysts going forward.
Via
InvestorPlace
Exelixis' Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest
August 24, 2023
Thursday, Exelixis Inc (NASDAQ: EXEL) announced that the Alliance for Clinical Trials in Oncology independent Data and Safety Monitoring Board (DSMB) unanimously recommended to unblind and stop the...
Via
Benzinga
Cheaper Version Of Blockbuster Arthritis Treatment Humira - CVS Health Teams With Sandoz
August 24, 2023
CVS Health Corp (NYSE: CVS) has launched Cordavis, a wholly-owned subsidiary, to work directly with manufacturers to commercialize and/or co-produce biosimilar
Via
Benzinga
Could This Medicine Be the Next Winner for Novartis?
August 23, 2023
The Swiss drugmaker recently reported that a drug candidate met the primary endpoints in phase 3 clinical trials.
Via
The Motley Fool
Gold Rush In Weight Loss Industry Impacts Retailers With Pharmacy Businesses
August 22, 2023
Retailers with pharmacy businesses, including major players like Walmart Inc (NYSE: WMT), Kroger Company (NYSE: KR), and Rite Aid Corp (NYSE:
Via
Benzinga
A Comprehensive Study Exploring Breast Cancer Drugs Market : Key Players- Sanofi, Novartis, Lilly
August 21, 2023
The Global Breast Cancer Drugs Market offers energetic visions to conclude market size, opportunities, growth pattern, and competitive surroundings. The research is derived through primary and...
Via
SBWire
Why This Regeneron Approval 'Could Not Come Soon Enough' As Novartis Looms
August 21, 2023
The FDA signed off on Regeneron's high-dose Eylea about two months earlier than expected.
Via
Investor's Business Daily
Exposures
Product Safety
SpaceX On Par With Intel, Disney; US Weight Loss Drugs Pricier; Moderna, Pfizer's Shot Effective Against New Variant: Today's Top Stories
August 18, 2023
Benzinga
Via
Benzinga
Merck Reveals Mixed Results From Pivotal Kidney Cancer Study Of Welireg In Pretreated Patients
August 18, 2023
Merck & Co Inc (NYSE: MRK) released topline results from LITESPARK-005, a Phase 3 trial investigating WELIREG (belzutifan), Merck's oral hypoxia-inducible
Via
Benzinga
Novartis' Generic Business Spinoff: Plans Sandoz Spin-Off In Early October, Proposes Share Distribution
August 18, 2023
Novartis AG (NYSE: NVS)
Via
Benzinga
COPD & Asthma Devices Market to Witness Remarkable Growth by 2029 : Pfizer, GSK, Novartis, Merck
August 17, 2023
Stay up to date with COPD & Asthma Devices Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Addiction Treatment Market May See New Emerging Trends: Novartis, Pfizer, Sanofi
August 17, 2023
Pune, Maharashtra -- (SBWIRE) -- 08/17/2023 -- 2023-2031 Report on Global Addiction Treatment Market by Player, Region, Type, Application and Sales Channel is the latest research study released by HTF...
Via
SBWire
Essential Thrombocythemia Market Projected to Show Strong Growth : Pharmaessentia, Bristol Myers Squibb, Shire
August 14, 2023
Get an extensive Essential Thrombocythemia Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
3 Unstoppable Dividend Stocks to Buy Right Now
August 12, 2023
These stocks' dividends are more dependable than most.
Via
The Motley Fool
Immuno Oncology Market May See a Big Move : AstraZeneca, Bristol Myers Squibb, F. Hoffmann-La Roche
August 09, 2023
Stay up-to-date with Immuno Oncology Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Novartis's Remibrutinib Shows Rapid Improvement In Type Of Skin Disorder That Impacts 40M People
August 09, 2023
Novartis AG (NYSE: NVS)
Via
Benzinga
Hypertrophic Cardiomyopathy Therapeutics Market Projected to Show Strong Growth : Novartis, Gilead Sciences, ADVANZ PHARMA
August 08, 2023
Stay up-to-date with Hypertrophic Cardiomyopathy Therapeutics Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Multiple Myeloma Therapy Market Projected to Show Strong Growth : Hikma Pharmaceutical, Eagle Pharmaceuticals, Janssen Biotech
August 08, 2023
Get Multiple Myeloma Therapy Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis.
Via
SBWire
The Year’s Top 3 International ETFs as of August 2023
August 07, 2023
By investing in international ETFs, you can mitigate potential losses with a more diversified portfolio. Here are three with strong returns.
Via
InvestorPlace
Blockbuster Drugs Market Projected to Show Strong Growth : Celgene, Bristol-Myers Squibb, Pfizer
August 03, 2023
Get an extensive Blockbuster Drugs Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
39
40
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.